252 related articles for article (PubMed ID: 22530031)
1. The spatial distribution of LGR5+ cells correlates with gastric cancer progression.
Simon E; Petke D; Böger C; Behrens HM; Warneke V; Ebert M; Röcken C
PLoS One; 2012; 7(4):e35486. PubMed ID: 22530031
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
3. Expression of 5-HT Relates to Stem Cell Marker LGR5 in Patients with Gastritis and Gastric Cancer.
Niu Q; Li L; Zhang C; Qi C; He Q; Zhu Y
Dig Dis Sci; 2023 May; 68(5):1864-1872. PubMed ID: 36436157
[TBL] [Abstract][Full Text] [Related]
4. Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response.
Freiin Grote A; Halske C; Behrens HM; Krüger S; Wilhelm F; Egberts JH; Röcken C
Dis Markers; 2019; 2019():8154926. PubMed ID: 31827644
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
[TBL] [Abstract][Full Text] [Related]
6. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
7. Distribution of LGR5+ cells and associated implications during the early stage of gastric tumorigenesis.
Jang BG; Lee BL; Kim WH
PLoS One; 2013; 8(12):e82390. PubMed ID: 24340024
[TBL] [Abstract][Full Text] [Related]
8. Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa--with special emphasis on participation in intestinal metaplasia of the human stomach.
Mizoshita T; Inada K; Tsukamoto T; Kodera Y; Yamamura Y; Hirai T; Kato T; Joh T; Itoh M; Tatematsu M
Gastric Cancer; 2001; 4(4):185-91. PubMed ID: 11846061
[TBL] [Abstract][Full Text] [Related]
9. A Study on the Mechanism of Low-Expressed Cancer Stem Cell Marker Lgr5 in Inhibition of the Proliferation and Invasion of Colorectal Carcinoma.
Jia H; Xiang L; Wang Z; Zhou Q
Cell Biochem Biophys; 2015 Nov; 73(2):393-397. PubMed ID: 27352328
[TBL] [Abstract][Full Text] [Related]
10. LGR4 and LGR6 are differentially expressed and of putative tumor biological significance in gastric carcinoma.
Steffen JS; Simon E; Warneke V; Balschun K; Ebert M; Röcken C
Virchows Arch; 2012 Oct; 461(4):355-65. PubMed ID: 22855134
[TBL] [Abstract][Full Text] [Related]
11. H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer.
Uehara T; Ma D; Yao Y; Lynch JP; Morales K; Ziober A; Feldman M; Ota H; Sepulveda AR
Dig Dis Sci; 2013 Jan; 58(1):140-9. PubMed ID: 22945475
[TBL] [Abstract][Full Text] [Related]
12. Sequential expression of putative stem cell markers in gastric carcinogenesis.
Wang T; Ong CW; Shi J; Srivastava S; Yan B; Cheng CL; Yong WP; Chan SL; Yeoh KG; Iacopetta B; Salto-Tellez M
Br J Cancer; 2011 Aug; 105(5):658-65. PubMed ID: 21829201
[TBL] [Abstract][Full Text] [Related]
13. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers.
Wu C; Xie Y; Gao F; Wang Y; Guo Y; Tian H; Li Y; Fan W
Gene; 2013 Aug; 525(1):18-25. PubMed ID: 23664892
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Musashi-1, Lgr5, and pEGFR expressions in human small intestinal adenocarcinomas.
Wang Y; Jiang CQ; Fan LF
Tumour Biol; 2015 Aug; 36(8):6075-82. PubMed ID: 25773390
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma.
Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX
Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of LGR5 correlates with poor survival of colon cancer in mice as well as in patients.
Liu Z; Dai W; Jiang L; Cheng Y
Neoplasma; 2014; 61(2):177-85. PubMed ID: 24063790
[TBL] [Abstract][Full Text] [Related]
17. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.
Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339
[TBL] [Abstract][Full Text] [Related]
18. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
19. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.
Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C
Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017
[TBL] [Abstract][Full Text] [Related]
20. Gastric Lgr5(+) stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice.
Li XB; Yang G; Zhu L; Tang YL; Zhang C; Ju Z; Yang X; Teng Y
Cell Res; 2016 Jul; 26(7):838-49. PubMed ID: 27091432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
